Signal transduction protein array analysis links LRRK2 to Ste20 kinases and PKC zeta that modulate neuronal...

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Dominant mutations in leucine-rich repeat kinase 2 (LRRK2) are a common genetic cause of Parkinson's disease (PD).
• The pathogenic mechanisms of LRRK2 mutations, particularly LRRK2(G2019S), remain poorly understood.
• LRRK2 has known links to kinase families, but its specific signaling pathways are not fully elucidated.

Purpose of the Study:

• To identify kinase signaling pathways involving leucine-rich repeat kinase 2 (LRRK2).
• To uncover novel LRRK2 substrates and interacting proteins.
• To investigate the role of LRRK2 in neuronal function and Parkinson's disease.

Main Methods:

• Utilized an unbiased proteomic approach.
• Employed protein microarrays containing 260 signal transduction proteins.
• Performed in vitro and in vivo experiments to study protein kinase C (PKC) zeta interactions with LRRK2.

Main Results:

• Identified four Ste20 serine/threonine kinase family members (TAOK3, STK3, STK24, STK25) as novel LRRK2 substrates and interacting proteins.
• Discovered that protein kinase C (PKC) zeta binds and phosphorylates LRRK2 both in vitro and in vivo.
• Demonstrated LRRK2's involvement in kinase signaling pathways.

Conclusions:

• Ste20 kinases and PKC zeta contribute to physiological neuronal processes like Tau phosphorylation, neurite outgrowth, and synaptic plasticity.
• These kinases may play a role in synaptic dysfunction and neurite fragmentation observed in Parkinson's disease.
• The findings provide new insights into the molecular mechanisms underlying LRRK2-associated Parkinson's disease.